Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3006 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 21 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2747 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-03-16 | 2023-03-30 | 187241 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-23 | 2023-08-04 | 196315 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-29 | 2023-08-04 | 196952 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2023-09-07 | 2023-10-15 | 203825 |
| APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2023-09-28 | 2023-10-15 | 205495 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-10-27 | 2023-12-01 | 208388 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209954 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-02-23 | 2024-03-29 | 220456 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223058 |
| APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-03-10 | 2017-04-27 | 399 |
| APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-11-07 | 2018-03-27 | 28556 |
| APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2018-01-18 | 2018-03-13 | 36435 |
| APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2018-04-10 | 2019-07-17 | 45365 |
| APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2018-05-02 | 2018-07-12 | 47966 |
| APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2019-10-30 | 2020-03-09 | 97474 |
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2022-06-06 | 2022-09-06 | 162094 |
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2023-08-18 | 2023-12-01 | 202397 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2017-05-04 | 2017-07-04 | 8877 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2017-09-05 | 2017-10-16 | 20927 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
| APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
| APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 |